Jump to content

Drilldown: Medicines

Pharmacopedia
BrowseCategoriesLog in

Choose a table:


Medicines > classes : Classic Psychedelic or Neuroleptic or [[:Category:Antiasthmatic_agents|Antiasthmatic]]

Use the filters below to narrow your results.

generic:
brand:
None (69) · Delysid (historical, Sandoz, withdrawn 1965) (1) · Fanapt (1) · Geodon (1) · Inapsine (1) · Invega (1) · Latuda (1) · Loxitane (1) · Mellaril (1) · Moban (1) · Navane (1) · Orap (1) · Prolixin (1) · Saphris (1) · Singulair (1) · Stelazine (1) · Thorazine (1) · Trilafon (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Phenothiazine D2 antagonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · Contains LSA (2) · Contains mescaline (2)
uses:
None (85) · '"`UNIQ--vote-0000015B-QINU`"', '"`UNIQ--vote-0000015C-QINU`"', '"`UNIQ--vote-0000015D-QINU`"' (1)
starting dose:
None (85) · 10 mg PO once daily in the evening (adults); 4-5 mg in children (1)
preparations:
None (85) · 10 mg tablets; 4 mg, 5 mg chewables; 4 mg granules (1)
fda max:
None (85) · 10 mg/d (adults) (1)
routes:
None (84) · Oral (2)
onset:
None (84) · 30–60 minutes (1) · Bronchodilation within 1-2 hours; full controller effect 1-2 weeks (1)
duration:
None (84) · 24 hours (1) · 8–12 hours (1)
halflife:
None (84) · 2.7-5.5 hours'"`UNIQ--ref-0000015E-QINU`"' (1) · 3–5 hours (1)
bioavailability:
None (84) · 70–90% (oral) (1) · ~64% (oral; not significantly affected by food)'"`UNIQ--ref-0000015F-QINU`"' (1)
pregnancy:
None (84) · Generally considered safe; pregnancy registries do not show increased major malformation risk.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1) · Not established (1)
legal:
None (84) · Schedule I (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US. '''FDA Boxed Warning (2020):''' neuropsychiatric events including agitation, depression, sleep disturbance, and suicidal thoughts; benefit-risk should be reassessed regularly'"`UNIQ--ref-00000160-QINU`"'. (1)

Showing below up to 86 results in range #1 to #86.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"